Latest News on MDT

Financial News Based On Company


Advertisement
Advertisement

1 Reason I'm Watching Intuitive Surgical Stock in 2026

https://www.fool.com/investing/2025/10/07/1-reason-im-watching-hot-ticker-stock-in-2026/
The surgical robotics pioneer could cement its leading position for years to come.

Medtronic ( MDT ) Beats Stock Market Upswing: What Investors Need to Know

https://www.zacks.com/stock/news/2761867/medtronic-mdt-beats-stock-market-upswing-what-investors-need-to-know
Medtronic (MDT) closed the most recent trading day at $97.7, moving +2.33% from the previous trading session.

Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization

https://www.globenewswire.com/news-release/2025/10/02/3160344/0/en/Dentsply-Sirona-Appoints-Aldo-M-Denti-as-Chief-Commercial-Officer-and-Announces-Customer-Centric-Organization.html
CHARLOTTE, N.C., Oct. 02, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) ( Nasdaq: XRAY ) today announced that Aldo M. Denti has been appointed Executive Vice President and Chief Commercial Officer ( CCO ) , effective October 6, 2025.

Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization - Dentsply Sirona ( NASDAQ:XRAY )

https://www.benzinga.com/pressreleases/25/10/g47991469/dentsply-sirona-appoints-aldo-m-denti-as-chief-commercial-officer-and-announces-customer-centric-o
CHARLOTTE, N.C., Oct. 02, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) ( NASDAQ:XRAY ) today announced that Aldo M. Denti has been appointed Executive Vice President and Chief Commercial Officer ( CCO ) , effective October 6, 2025.

Meet the 3%-Yielding Dividend Stock That Could Soar in 2026

https://www.fool.com/investing/2025/10/02/meet-the-3-yielding-dividend-stock-that-could-soar/
The growth of surgical robots is huge, and this company is looking to get in on the action while it also works to boost its profit margin.
Advertisement

This Medical Device Giant Could Be Your Best Inflation Hedge

https://www.fool.com/investing/2025/10/02/this-medical-device-giant-could-be-your-best-infla/
The stock can bring stability amid volatile economic conditions.

ISRG Expands SP Indications: A Game Changer in Colorectal Surgery?

https://www.zacks.com/stock/news/2760280/isrg-expands-sp-indications-a-game-changer-in-colorectal-surgery
Intuitive Surgical's SP platform secures new colorectal clearances, with 88% growth in procedures and rising global adoption momentum.

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

https://www.zacks.com/stock/news/2758892/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Agilent ( A ) Down 2.5% Since Last Earnings Report: Can It Rebound?

https://www.zacks.com/stock/news/2757832/agilent-a-down-25-since-last-earnings-report-can-it-rebound
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Medtronic ( MDT ) Suffers a Larger Drop Than the General Market: Key Insights

https://www.zacks.com/stock/news/2757346/medtronic-mdt-suffers-a-larger-drop-than-the-general-market-key-insights
In the closing of the recent trading day, Medtronic (MDT) stood at $94.3, denoting a -1.5% move from the preceding trading day.
Advertisement

SoCalBio Investor Conference Sessions to Spotlight Bioscience Workforce Development, Technology Transfer, and AI-Driven Innovation

https://www.benzinga.com/pressreleases/25/09/g47875933/socalbio-investor-conference-sessions-to-spotlight-bioscience-workforce-development-technology-tra
LOS ANGELES, Sept. 25, 2025 ( GLOBE NEWSWIRE ) -- The Southern California Biomedical Council ( SoCalBio ) today announced the final lineup of expert panels for its 27th Annual Investor & Partnership Conference, taking place October 1-2 at the Hyatt Regency Newport Beach.

Here's Why Medtronic ( MDT ) is a Strong Value Stock

https://www.zacks.com/stock/news/2757003/heres-why-medtronic-mdt-is-a-strong-value-stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Ultimate High Yield Healthcare Stock to Buy With $10,000 Right Now

https://www.fool.com/investing/2025/09/25/the-ultimate-high-yield-healthcare-stock-to-buy-wi/
Surgical technology is advancing quickly, and robots are the future, which is why you'll want to look at this high-yield surgical robot maker.

Medtronic Receives FDA Nod for Altaviva Device: Stock to Gain?

https://www.zacks.com/stock/news/2756200/medtronic-receives-fda-nod-for-altaviva-device-stock-to-gain
MDT gains FDA approval for its Altaviva device, a minimally invasive bladder control therapy with long-lasting benefits.

Robotics and MedSurg Drive Stryker Growth Amid Margin Pressures

https://www.zacks.com/stock/news/2756178/robotics-and-medsurg-drive-stryker-growth-amid-margin-pressures
SYK posts 11% sales growth and EPS beat for Q2, driven by Mako robotics and MedSurg strength, but faces cost and margin headwinds.
Advertisement

The Ultimate Dividend King Drug Stock to Buy With $1,000 Right Now

https://www.fool.com/investing/2025/09/23/the-ultimate-dividend-king-drug-stock-to-buy-1000/
This out-of-favor industry could be in the doghouse for years. Do you buy for yield or for dividend safety?

1 Reason Medtronic ( MDT ) Is One of the Best Healthcare Stocks You Can Buy Today

https://www.fool.com/investing/2025/09/22/1-reason-medtronic-mdt-is-one-of-the-best-healthca/
Medtronic is one of the largest medical device makers in the world, and it is focused on getting more profitable.

Medtronic's New Implant Could Transform Bladder Control Treatment - Medtronic ( NYSE:MDT )

https://www.benzinga.com/news/fda/25/09/47764264/medtronics-new-implant-could-transform-bladder-control-treatment
Innovative medical technologies are transforming healthcare by tackling chronic conditions that affect millions, offering hope and improved quality of life. The Food and Drug Administration ( FDA ) approved Medtronic plc's MDT Altaviva device on Friday.

Medtronic ( MDT ) Up 1.5% Since Last Earnings Report: Can It Continue?

https://www.zacks.com/stock/news/2753535/medtronic-mdt-up-15-since-last-earnings-report-can-it-continue
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Neuromodulation Market is expected to generate a revenue of USD 9.32 Billion by 2032, Globally, at 9.27% CAGR: Verified Market Research®

https://www.benzinga.com/pressreleases/25/09/g47739392/neuromodulation-market-is-expected-to-generate-a-revenue-of-usd-9-32-billion-by-2032-globally-at-9
Lewes, Delaware, Sept. 18, 2025 ( GLOBE NEWSWIRE ) -- The Global Neuromodulation Market Size is projected to grow at a CAGR of 9.27% from 2026 to 2032, according to a new report published by Verified Market Research®.
Advertisement

Smart Money Is Betting Big In MDT Options - Medtronic ( NYSE:MDT )

https://www.benzinga.com/insights/options/25/09/47726154/smart-money-is-betting-big-in-mdt-options
Financial giants have made a conspicuous bullish move on Medtronic. Our analysis of options history for Medtronic MDT revealed 12 unusual trades. Delving into the details, we found 41% of traders were bullish, while 41% showed bearish tendencies.

1 Reason Every Investor Should Know About Medtronic ( MDT )

https://www.fool.com/investing/2025/09/17/1-reason-every-investor-should-know-medtronic/
The storied medical device specialist always seems to post encouraging growth.

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields - AbbVie ( NYSE:ABBV ) , Medtronic ( NYSE:MDT )

https://www.benzinga.com/trading-ideas/dividends/25/09/47711324/wall-streets-most-accurate-analysts-weigh-in-on-3-health-care-stocks-with-over-3-dividend
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Cirtec Medical Welcomes Chris Cleary to its Board of Directors

https://www.benzinga.com/pressreleases/25/09/g47700694/cirtec-medical-welcomes-chris-cleary-to-its-board-of-directors
BROOKLYN PARK, Minn., Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- Cirtec Medical is pleased to announce that Chris Cleary has been appointed to its Board of Directors.

1 Reason Intuitive Surgical ( ISRG ) Is 1 of the Best Healthcare Stocks You Can Buy Today

https://www.fool.com/investing/2025/09/16/1-reason-isrg-is-1-of-the-best-healthcare-stocks-y/
Find out how the company's da Vinci surgical robots could remain the preferred option for decades.
Advertisement

ISRG Stock Down More than 13% in 3 Months: How to Play the Stock?

https://www.zacks.com/stock/news/2751330/isrg-stock-down-more-than-13-in-3-months-how-to-play-the-stock
Intuitive Surgical shares are down 13% in three months as margin pressures weigh on the stock, but strong procedure growth keeps its long-term story intact.

Billionaire Phillipe Laffont Sold Coatue Management's Stake in Super Micro Computer and Snapped Up This Surgical Robotics Pioneer That's Up 19,390% Since Its IPO

https://www.fool.com/investing/2025/09/14/billionaire-phillipe-laffont-sold-coatue-managemen/
An unbeatable advantage makes this stock a popular one among billionaire investors.

Billionaire Ken Griffin Piled Into These 2 Unstoppable Dividend Stocks During the Second Quarter

https://www.fool.com/investing/2025/09/13/billionaire-ken-griffin-piled-into-these-2-unstopp/
They have increased their payouts for a combined 111 straight years.

How Do Investors Really Feel About Medtronic? - Medtronic ( NYSE:MDT )

https://www.benzinga.com/insights/short-sellers/25/09/47628430/how-do-investors-really-feel-about-medtronic
Medtronic's MDT short interest as a percent of float has fallen 6.36% since its last report. According to exchange reported data, there are now 13.23 million shares sold short, which is 1.03% of all regular shares that are available for trading.

Ion Platform Poised for Cost Optimization: A Margin Lever for ISRG?

https://www.zacks.com/stock/news/2749201/ion-platform-poised-for-cost-optimization-a-margin-lever-for-isrg
Intuitive Surgical's Ion platform is driving rapid growth, but cost optimization could be the key to turning it from a margin drag to a margin lever.
Advertisement

OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System

https://www.globenewswire.com/news-release/2025/09/10/3147629/0/en/OrthoPediatrics-Corp-Completes-First-Procedures-with-VerteGlide-Spinal-Growth-Guidance-System.html
WARSAW, Ind., Sept. 10, 2025 ( GLOBE NEWSWIRE ) -- OrthoPediatrics Corp. ( "OrthoPediatrics" or the "Company" ) ( Nasdaq: KIDS ) , a company focused exclusively on advancing the field of pediatric orthopedics, today announced the completion of the first U.S. surgical procedures with the ...

Disposable Endoscopes Market is expected to generate a revenue of USD 7.31 Billion by 2032, Globally, at 17.24% CAGR: Verified Market Research®

https://www.benzinga.com/pressreleases/25/09/g47548550/disposable-endoscopes-market-is-expected-to-generate-a-revenue-of-usd-7-31-billion-by-2032-globall
Lewes, Delaware, Sept. 08, 2025 ( GLOBE NEWSWIRE ) -- The Global Disposable Endoscopes Market Size is projected to grow at a CAGR of 17.24% from 2026 to 2032, according to a new report published by Verified Market Research®.

2 Beaten-Down Stocks to Buy on the Dip

https://www.fool.com/investing/2025/09/07/2-beaten-down-stocks-to-buy-on-the-dip/
The market may be overlooking these companies' long-term potential.

Medtronic's Hugo Robotic System Achieves 100% Success Rate In Hernia Repair Trial - Medtronic ( NYSE:MDT )

https://www.benzinga.com/news/health-care/25/09/47523862/medtronics-hugo-robotic-system-achieves-100-success-rate-in-hernia-repair-trial
Enable Hernia Repair is the first-ever Investigational Device Exemption clinical study completed for robotic-assisted hernia surgery in U.S. Inguinal patients had 0% surgical site events, well below the 30% benchmark. September's volatility catalysts are coming.

3 High-Yielding Dividend Stocks to Buy and Hold For the Long Haul

https://www.fool.com/investing/2025/09/05/3-high-yielding-dividend-stocks-to-buy-and-hold/
These income stocks offer above-average yields, have strong fundamentals, and should offer investors a lot of stability over the long run.
Advertisement

MDT Stock May Benefit From New Regulatory Wins for Its MiniMed 780G

https://www.zacks.com/stock/news/2747460/mdt-stock-may-benefit-from-new-regulatory-wins-for-its-minimed-780g
Medtronic secures FDA milestones for its MiniMed 780G system, expanding use to type 2 diabetes and enabling sensor integration.

Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout

https://www.globenewswire.com/news-release/2025/09/04/3145007/0/en/Orchestra-BioMed-Presents-New-AVIM-Therapy-Clinical-Data-at-HRX-Demonstrating-Substantial-and-Sustained-Blood-Pressure-Reductions-that-are-Reproducible-Upon-Reactivation-Following-.html
NEW HOPE, Pa., Sept. 04, 2025 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced new data from its AVIM ...

Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout - Medtronic ( NYSE:MDT ) , Orchestra BioMed Hldgs ( NASDAQ:OBIO )

https://www.benzinga.com/pressreleases/25/09/g47511343/orchestra-biomed-presents-new-avim-therapy-clinical-data-at-hrx-demonstrating-substantial-and-sust
Results from long-term follow up of patients treated with atrioventricular interval modulation ( "AVIM" ) therapy show blood pressure-lowering effects are sustained for years after activation, reversible with no observed rebound hypertension upon deactivation of treatment, and reproducible upon ...

ISRG's SP Stapler: A Game Changer for Colorectal and Thoracic Procedures?

https://www.zacks.com/stock/news/2746481/isrgs-sp-stapler-a-game-changer-for-colorectal-and-thoracic-procedures
Intuitive Surgical's new SP stapler opens doors to colorectal and thoracic surgeries, potentially transforming the single-port platform's adoption curve.

Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth - Fractyl Health ( NASDAQ:GUTS )

https://www.benzinga.com/pressreleases/25/09/g47468714/fractyl-health-expands-board-of-directors-with-appointments-of-industry-leaders-to-advance-clinica
BURLINGTON, Mass., Sept. 03, 2025 ( GLOBE NEWSWIRE ) -- Fractyl Health, Inc. GUTS ( the Company or Fractyl ) , a metabolic therapeutics company focused on pattern breaking approaches that treat root causes of obesity and type 2 diabetes ( T2D ) , today announced the appointments of Christopher ...
Advertisement

Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth

https://www.globenewswire.com/news-release/2025/09/03/3143427/0/en/Fractyl-Health-Expands-Board-of-Directors-with-Appointments-of-Industry-Leaders-to-Advance-Clinical-Execution-and-Strategic-Growth.html
Appointments include Christopher Thompson, M.D. and Ian Sheffield as Independent Directors Appointments include Christopher Thompson, M.D. and Ian Sheffield as Independent Directors ...

Nvidia Just Posted 56% Sales Growth, but the Market Shrugged. Should You?

https://www.fool.com/investing/2025/09/03/nvidia-56-sales-growth-ai-the-market-shrugged-buy/
CEO Jensen Huang already told investors what Nvidia's next growth catalyst will be.

Pharming Group appoints Kenneth Lynard as Chief Financial Officer

https://www.globenewswire.com/news-release/2025/09/02/3142312/0/en/Pharming-Group-appoints-Kenneth-Lynard-as-Chief-Financial-Officer.html
Leiden, the Netherlands, September 2, 2025: Pharming Group N.V. ( "Pharming" or "the Company" ) ( Euronext: PHARM. Nasdaq: PHAR ) today announced the appointment of Kenneth Lynard as Chief Financial Officer ( CFO ) , effective October 1, 2025.

Pharming Group appoints Kenneth Lynard as Chief Financial Officer - Pharming ( NASDAQ:PHAR )

https://www.benzinga.com/pressreleases/25/09/g47441375/pharming-group-appoints-kenneth-lynard-as-chief-financial-officer
Leiden, the Netherlands, September 2, 2025: Pharming Group N.V. ( "Pharming" or "the Company" ) ( PHARMPHAR today announced the appointment of Kenneth Lynard as Chief Financial Officer ( CFO ) , effective October 1, 2025.

3 Best Dividend Stocks to Buy Now

https://www.fool.com/investing/2025/08/30/3-best-dividend-stocks-to-buy-now/
Companies that have increased their dividends annually for 25 consecutive years are a rare breed. These three also stand out for their attractive yields.
Advertisement

Why Medtronic Has Been Stuck for Over 1,100 Days And What Lies Ahead - Jack Henry & Associates ( NASDAQ:JKHY ) , Medtronic ( NYSE:MDT )

https://www.benzinga.com/markets/equities/25/08/47414818/why-medtronic-has-been-stuck-for-over-1-100-days-and-what-lies-ahead
Medtronic MDT has been trapped in a tight consolidation band for what feels like forever. For more than 1,100 days, the stock has stubbornly stayed between $75 and $95, showing little sign of life.

ISRG vs. MDT: Which MedTech Titan Is the Stronger Investment Choice Now?

https://www.zacks.com/stock/news/2743986/isrg-vs-mdt-which-medtech-titan-is-the-stronger-investment-choice-now
ISRG's strong double-digit robotic growth stands in contrast to MDT's diversified portfolio and more attractive valuation, setting up a compelling medtech comparison.

Here's Why Medtronic ( MDT ) is a Strong Momentum Stock

https://www.zacks.com/stock/news/2742883/heres-why-medtronic-mdt-is-a-strong-momentum-stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Medtronic To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Tuesday - Cemex ( NYSE:CX ) , Albemarle ( NYSE:ALB )

https://www.benzinga.com/news/25/08/47331705/medtronic-to-rally-around-25-here-are-10-top-analyst-forecasts-for-tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. UBS raised Albemarle Corporation ALB price target from $62 to $89.

Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology

https://www.globenewswire.com/news-release/2025/08/26/3139160/0/en/Orchestra-BioMed-Announces-Publication-of-Clinical-Data-Demonstrating-Favorable-Blood-Pressure-and-Hemodynamic-Effects-of-AVIM-Therapy-in-JACC-Clinical-Electrophysiology.html
NEW HOPE, Pa., Aug. 26, 2025 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the publication of data in ...
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement